Bei Lin Selected Research

Ovarian Neoplasms (Ovarian Cancer)

3/2024	ST14 interacts with TMEFF1 and is a predictor of poor prognosis in ovarian cancer.
6/2023	PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation.
1/2023	Oxidative Stress Response Biomarkers of Ovarian Cancer Based on Single-Cell and Bulk RNA Sequencing.
12/2022	HERPUD1 promotes ovarian cancer cell survival by sustaining autophagy and inhibit apoptosis via PI3K/AKT/mTOR and p38 MAPK signaling pathways.
6/2022	Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer.
6/2022	Interaction between TMEFF1 and AHNAK proteins in ovarian cancer cells: Implications for clinical prognosis.
1/2022	RAD21 Confers Poor Prognosis and Affects Ovarian Cancer Sensitivity to Poly(ADP-Ribose)Polymerase Inhibitors Through DNA Damage Repair.
1/2022	Prognostic biomarker MCP-4 triggers epithelial-mesenchymal transition via the p38 MAPK pathway in ovarian cancer.
1/2022	miRNA-651-3p regulates EMT in ovarian cancer cells by targeting ZNF703 and via the MEK/ERK pathway.
1/2022	Human Epididymis Protein 4 and Lewis y Enhance Chemotherapeutic Resistance in Epithelial Ovarian Cancer Through the p38 MAPK Pathway.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bei Lin Research Topics

Disease

76	Ovarian Neoplasms (Ovarian Cancer) 03/2024 - 04/2003
57	Neoplasms (Cancer) 03/2024 - 04/2003
27	Ovarian Epithelial Carcinoma 01/2022 - 04/2003
20	Carcinoma (Carcinomatosis) 06/2023 - 01/2005
15	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2010
12	Endometrial Neoplasms (Endometrial Cancer) 01/2023 - 04/2005
10	Lymphatic Metastasis 01/2021 - 04/2003
4	Carcinogenesis 01/2020 - 09/2010
3	Residual Neoplasm 07/2017 - 11/2012
2	Adenocarcinoma 01/2023 - 05/2013
2	Hypoxia (Hypoxemia) 01/2022 - 09/2016
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2012 - 11/2004
1	Carcinosarcoma 01/2023
1	Endometrioid Carcinoma 01/2023
1	Developmental Dysplasia of the Hip 11/2022
1	Papillary Thyroid Microcarcinoma 01/2022
1	Breast Neoplasms (Breast Cancer) 11/2020
1	Cicatrix (Scar) 11/2020
1	Infections 01/2020

Drug/Important Bio-Agent (IBA)

37	Proteins (Proteins, Gene)FDA Link 03/2024 - 03/2009
35	Lewis Y antigenIBA 12/2022 - 03/2008
20	Biomarkers (Surrogate Marker)IBA 06/2023 - 10/2012
13	Messenger RNA (mRNA)IBA 06/2023 - 07/2004
9	AntigensIBA 12/2022 - 01/2013
7	IntegrinsIBA 06/2015 - 07/2010
6	Annexin A2 (Annexin II)IBA 12/2021 - 11/2014
5	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2018
5	OligosaccharidesIBA 06/2015 - 06/2008
4	ParaffinIBA 01/2023 - 01/2015
4	RNA (Ribonucleic Acid)IBA 01/2023 - 10/2012
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 01/2020
4	Carboplatin (JM8)FDA LinkGeneric 06/2015 - 07/2004
3	p38 Mitogen-Activated Protein KinasesIBA 12/2022 - 01/2022
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 11/2020
3	Transcription Factors (Transcription Factor)IBA 11/2020 - 02/2015
3	Long Noncoding RNAIBA 04/2020 - 01/2020
3	Competitive Endogenous RNAIBA 01/2020 - 01/2018
3	Small Interfering RNA (siRNA)IBA 01/2020 - 10/2012
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 11/2004
3	CarbohydratesIBA 12/2017 - 01/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 09/2010
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022 - 11/2020
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021 - 01/2020
2	EnzymesIBA 01/2021 - 04/2012
2	ChromatinIBA 11/2020 - 12/2017
2	LuciferasesIBA 11/2020 - 12/2017
2	PlatinumIBA 11/2020 - 01/2015
2	Estrogens (Estrogen)FDA Link 03/2020 - 02/2015
2	Estrogen ReceptorsIBA 03/2020 - 02/2015
2	AnnexinsIBA 01/2020 - 01/2019
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 09/2010
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 04/2019 - 11/2010
2	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2017 - 12/2012
2	TransferasesIBA 09/2016 - 09/2008
2	OligonucleotidesIBA 12/2015 - 01/2015
2	Beclin-1IBA 03/2014 - 12/2012
2	Complementary DNA (cDNA)IBA 02/2013 - 11/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 10/2012 - 07/2004
2	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2012 - 04/2012
2	GlycolipidsIBA 01/2011 - 01/2005
2	Monoclonal AntibodiesIBA 09/2010 - 03/2008
2	SurvivinIBA 07/2004 - 04/2003
1	Immunoglobulin E (IgE)IBA 01/2023
1	AntioxidantsIBA 01/2023
1	SugarsIBA 12/2022
1	Chemotactic FactorsIBA 01/2022
1	olaparibIBA 01/2022
1	cbr-5884IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2022
1	Serine (L-Serine)FDA Link 01/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2022
1	CateninsIBA 01/2022
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2022
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 12/2021
1	isothiocyanic acidIBA 10/2021
1	iberin (IMSP)IBA 10/2021
1	ChemokinesIBA 01/2021
1	Cladribine FDA LinkGeneric 01/2021
1	nelarabine (506U78)FDA Link 01/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021
1	GTP-Binding Proteins (G-Protein)IBA 01/2021
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2021
1	Keratins (Keratin)IBA 01/2021
1	SaltsIBA 11/2020
1	Therapeutic UsesIBA 11/2020
1	GlycosaminoglycansIBA 01/2020
1	PlakophilinsIBA 01/2020
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2020
1	anthrax toxin (anthrax lethal factor)IBA 01/2020
1	CytokinesIBA 01/2020
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2020
1	Proteoglycans (Proteoglycan)IBA 01/2020

Therapy/Procedure

16	Drug Therapy (Chemotherapy) 01/2023 - 07/2004
9	Therapeutics 03/2024 - 12/2012
3	Immunotherapy 06/2022 - 01/2015
1	Cytoreduction Surgical Procedures 01/2023
1	Hip Replacement Arthroplasty (Total Hip Replacement) 11/2022
1	Lymph Node Excision (Lymph Node Dissection) 01/2021
1	Immunomodulation 01/2020